Congenital dyserythropoietic anemia type IV
 | This article needs additional citations for verification. (May 2015) |
Congenital dyserythropoietic anemia type IV (CDA IV) has been described with typical morphologic features of CDA II but a negative acidified-serum test.[1]
| Congenital dyserythropoietic anemia type IV | |
|---|---|
| Specialty | Hematology  |
Genetics
Congenital dyserythropoietic anemia type IV is an autosomal dominant inherited red blood cell disorder characterized by ineffective erythropoiesis and hemolysis resulting in anemia. Circulating erythroblasts and erythroblasts in the bone marrow show various morphologic abnormalities. Affected individuals with CDAN4 also have increased levels of fetal hemoglobin.[2]
| Type | OMIM | Gene | Locus |
|---|---|---|---|
| CDAN4 | Template:OMIM2 | KLF1 | 19p13.13-p13.12 |
Description
CDA type IV is characterized by mild to moderate splenomegaly. Hemoglobin is very low and patients are transfusion dependent. MCV is normal or mildly elevated. Erythropoiesis is normoblastic or mildly to moderately megaloblastic. Nonspecific erythroblast dysplasia is present.[3]
Treatment
Treatment consists of frequent blood transfusions and chelation therapy. Potential cures include bone marrow transplantation and gene therapy.
See also
References
- ^ [1][dead link]
- ^ "ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE IV; CDAN4". Omim.org. Retrieved 6 May 2015.
- ^ Manual of Pediatric Hematology and Oncology - Google Books. Books.google.com. Retrieved 2015-05-06.[dead link]